<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Habib Ganfon</style></author><author><style face="normal" font="default" size="100%">Axel Ahouansou</style></author><author><style face="normal" font="default" size="100%">Celia Dechavanne</style></author><author><style face="normal" font="default" size="100%">Callinice Capo-Chichi</style></author><author><style face="normal" font="default" size="100%">Latifou Lagnika</style></author><author><style face="normal" font="default" size="100%">Agnes Aubouy</style></author><author><style face="normal" font="default" size="100%">Sebastien Dechavanne</style></author><author><style face="normal" font="default" size="100%">Achille Massougbodji</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cytotoxic Activity of Annona Muricata L, Momordica Charantia L. and Launaea Taraxacifolia Willd. from Benin: A Flow Cytometric Approach</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Benin</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant extracts</style></keyword><keyword><style  face="normal" font="default" size="100%">selectivity</style></keyword><keyword><style  face="normal" font="default" size="100%">THP-1 cells</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">727-732</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Cancer is rising worldwide, causing approximately 9.7 million deaths in 2022. Treatments are costly, have significant side effects, and are sometimes unavailable in Benin. Medicinal plants offer promising avenues for new therapeutic agents. &lt;strong&gt;Objective: &lt;/strong&gt;This study uses flow cytometry method to evaluate the cytotoxic activity of &lt;em&gt;Annona muricata&lt;/em&gt; (Annonaceae), &lt;em&gt;Momordica charantia&lt;/em&gt; (Cucurbitaceae) and &lt;em&gt;Launaea taraxacifolia&lt;/em&gt; (Asteraceae), three plants from the Beninese pharmacopoeia known for their anti-cancer properties. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The leaves of A. muricata, &lt;em&gt;L. taraxacifolia &lt;/em&gt;and whole plants of &lt;em&gt;M. charantia&lt;/em&gt; were collected in southern Benin. Extracts were prepared by aqueous decoction and sequential extraction with solvents of increasing polarity (dichloromethane, ethyl acetate, methanol). The phytochemical profiles of the extracts were determined using TLC and tube tests. The cytotoxicity of the extracts was evaluated on THP-1 cancer cells and PBMC healthy cells. After treatment with the extracts, cell viability was measured by flow cytometry after staining with Thiazole Orange and Hoechst 33258. &lt;strong&gt;Results:&lt;/strong&gt; The dichloromethane extracts of &lt;em&gt;A. muricata&lt;/em&gt; and &lt;em&gt;M. charantia&lt;/em&gt;, and the ethyl acetate extract of &lt;em&gt;M. charantia&lt;/em&gt; and&lt;em&gt; L. taraxacifolia &lt;/em&gt;showed significant cytotoxic effects on THP-1 cells. Their half-maximal inhibitory concentrations (IC&lt;sub&gt;50&lt;/sub&gt;) were 139.6 μg/mL, 72.89 μg/mL, 81.88 μg/mL and 106.3 μg/ mL, respectively. These extracts also demonstrated good selectivity toward normal cells. Phytochemical screening revealed the presence of alkaloids, coumarins, flavonoids, anthracene glycosides and triterpenes in the active extracts. &lt;strong&gt;Conclusion:&lt;/strong&gt; This study demonstrated the cytotoxic potential of three medicinal plants from the Beninese pharmacopoeia which may serve to develop further new anticancer therapies.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">727</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Habib Ganfon&lt;sup&gt;1*&lt;/sup&gt;, Axel Ahouansou&lt;sup&gt;1,2,3,4&lt;/sup&gt;, Célia Dechavanne&lt;sup&gt;2,5&lt;/sup&gt;, Callinice Capo- Chichi&lt;sup&gt;3&lt;/sup&gt;, Latifou Lagnika&lt;sup&gt;4&lt;/sup&gt;, Agnès Aubouy&lt;sup&gt;2,6&lt;/sup&gt;, Sébastien Dechavanne&lt;sup&gt;2,5&lt;/sup&gt;, Achille Massougbodji&lt;sup&gt;2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Laboratoire de Pharmacognosie et Phytothérapie du Centre de Recherche et de Développement du Médicament (CRDM-PharmaLab), 01 BP 188, Université d’Abomey-Calavi (UAC), BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institut de Recherche Clinique du Benin (IRCB), 04 BP 1114, Abomey-Calavi, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Laboratoire de recherche sur les Biomarqueurs Moléculaires en Cancérologie et en Nutrition, Unité de Biochimie et Biologie Moléculaire UAC, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Laboratoire de Biologie Intégrative pour l’Innovation Thérapeutique, Unité de Biochimie et des Substances Naturelles Bioactives, UAC, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;IRD, Inserm, MERIT, Université Paris Cité, F-75006 Paris, FRANCE&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;UMR 152 PHARMADEV, IRD, Université de Toulouse, FRANCE&lt;/p&gt;
</style></auth-address></record></records></xml>